Since dysregulation of maternal and fetal adipokines are linked to fetal growth and adiposity, the objective of this study was to determine whether the timing of exposure to diabetes during pregnancy (GDM versus pre-gestational T2D) impacts adiponectin, leptin and insulin levels in maternal serum and/or cord blood and whether these levels were associated with birthweight. This evidence concerns the gene INS and type 2 diabetes mellitus.